This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Practice Guideline

. 2018 Oct 1;29(Suppl 4):iv126-iv142.

doi: 10.1093/annonc/mdy145.

Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines

P Bossi¹, A Antonuzzo², N I Cherny³, O Rosengarten³, S Pernot⁴, F Trippa⁵, U Schuler⁶, A Snegovoy⁷, K Jordan⁸, C I Ripamonti⁹; ESMO Guidelines Committee

Affiliations

Affiliations

¹ Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano.
² U.O. Oncologia Medica 1, Polo Oncologico Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
³ Oncology Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
⁴ Department of Hepato-Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, APHP, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
⁵ Radiation Oncology Centre, "S. Maria" Hospital, Terni, Italy.
⁶ Department of Internal Medicine I, Palliative Care Centre, University Hospital Carl Gustav Carus, Dresden, Germany.
⁷ N.N. Blokhin Russian Cancer Research Center, Moscow, Russia.
⁸ Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
⁹ Oncology-Supportive Care in Cancer Unit, Department Onco-Haematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

PMID: 29931177
DOI: 10.1093/annonc/mdy145

Free article

Practice Guideline

Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines

P Bossi et al. Ann Oncol. 2018.

Free article

. 2018 Oct 1;29(Suppl 4):iv126-iv142.

doi: 10.1093/annonc/mdy145.

Authors

P Bossi¹, A Antonuzzo², N I Cherny³, O Rosengarten³, S Pernot⁴, F Trippa⁵, U Schuler⁶, A Snegovoy⁷, K Jordan⁸, C I Ripamonti⁹; ESMO Guidelines Committee

Affiliations

¹ Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano.
² U.O. Oncologia Medica 1, Polo Oncologico Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
³ Oncology Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
⁴ Department of Hepato-Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, APHP, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
⁵ Radiation Oncology Centre, "S. Maria" Hospital, Terni, Italy.
⁶ Department of Internal Medicine I, Palliative Care Centre, University Hospital Carl Gustav Carus, Dresden, Germany.
⁷ N.N. Blokhin Russian Cancer Research Center, Moscow, Russia.
⁸ Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
⁹ Oncology-Supportive Care in Cancer Unit, Department Onco-Haematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

PMID: 29931177
DOI: 10.1093/annonc/mdy145

No abstract available

PubMed Disclaimer

Publication types

Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information